Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Laura Dunn Goldberg, MD, is an Associate Staff research investigator in the Department of Orthopedic Sports Medicine at Cleveland Clinic's Lorain campus in Lorain, Ohio. She was appointed in 2006 as a primary care sports medicine staff member with the Department of Orthopedics, at Kolczun & Kolczun Orthopedic Associates in Lorain.
Previously, Dr. Goldberg was a pediatric emergency attending physician at University Hospital's Rainbow Babies and Children Hospital in Cleveland. She also served as a clinical research investigator at Case Western Reserve University in Cleveland and University of Vermont in Burlington, Vt.
Dr. Goldberg received her medical degree from University of Vermont College of Medicine in Burlington in 2002. She completed her pediatric residency at Case Western Reserve University Hospital's Rainbow Babies and Children’s Hospital in Cleveland, Ohio. In 2006, she completed her primary care sports medicine fellowship with the Cleveland Clinic's Department of Orthopedic Sports Medicine.
She is board-certified in both pediatrics and primary care sports medicine and is licensed to practice in Ohio. Dr. Goldberg is an author and presenter and a member of numerous professional societies including the American Medical Society of Sports Medicine, American Medical Athletic Association, the American College of Sports Medicine and the American Academy of Pediatrics.
In addition, Dr. Goldberg is an avid athlete, marathon runner and sailor. She has provided medical sports coverage for the Cleveland Browns (NFL), the Cleveland Cavaliers (NBA), the Cleveland Indians (Major League Baseball) and the Cleveland Barons (American Hockey League) among others.
General and pediatric orthopaedics, sports medicine, fracture care
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 8/12/2013, Dr. Goldberg has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.